ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/11 | 2,206 | 2,382 | 2,123 | 2,340 | +51 | +2.2% | 5,049,800 |
| 2025/03/10 | 2,263 | 2,405 | 2,217 | 2,289 | -162 | -6.6% | 5,411,900 |
| 2025/03/07 | 2,467 | 2,558 | 2,424 | 2,451 | -108 | -4.2% | 2,796,500 |
| 2025/03/06 | 2,556 | 2,687 | 2,381 | 2,559 | +84 | +3.4% | 8,270,700 |
| 2025/03/05 | 3,145 | 3,160 | 2,475 | 2,475 | -700 | -22% | 12,081,700 |
| 2025/03/04 | 3,335 | 3,345 | 3,140 | 3,175 | -195 | -5.8% | 1,165,300 |
| 2025/03/03 | 3,375 | 3,440 | 3,350 | 3,370 | -5 | -0.1% | 628,900 |
| 2025/02/28 | 3,375 | 3,525 | 3,350 | 3,375 | -70 | -2% | 839,500 |
| 2025/02/27 | 3,680 | 3,690 | 3,350 | 3,445 | -295 | -7.9% | 1,590,000 |
| 2025/02/26 | 3,730 | 3,845 | 3,715 | 3,740 | +20 | +0.5% | 747,300 |
| 2025/02/25 | 3,650 | 3,745 | 3,575 | 3,720 | -95 | -2.5% | 1,018,600 |
| 2025/02/21 | 3,850 | 3,915 | 3,780 | 3,815 | -70 | -1.8% | 911,900 |
| 2025/02/20 | 3,615 | 3,970 | 3,600 | 3,885 | +200 | +5.4% | 1,938,000 |
| 2025/02/19 | 3,750 | 3,765 | 3,645 | 3,685 | +60 | +1.7% | 1,099,700 |
| 2025/02/18 | 3,440 | 3,630 | 3,415 | 3,625 | +225 | +6.6% | 1,343,800 |
| 2025/02/17 | 3,300 | 3,550 | 3,280 | 3,400 | +45 | +1.3% | 1,711,100 |
| 2025/02/14 | 3,380 | 3,425 | 3,340 | 3,355 | +10 | +0.3% | 666,900 |
| 2025/02/13 | 3,270 | 3,345 | 3,215 | 3,345 | +35 | +1.1% | 774,800 |
| 2025/02/12 | 3,370 | 3,380 | 3,255 | 3,310 | -110 | -3.2% | 754,100 |
| 2025/02/10 | 3,300 | 3,440 | 3,285 | 3,420 | +15 | +0.4% | 578,900 |
| 2025/02/07 | 3,405 | 3,460 | 3,390 | 3,405 | -30 | -0.9% | 477,100 |
| 2025/02/06 | 3,300 | 3,435 | 3,295 | 3,435 | +160 | +4.9% | 666,100 |
| 2025/02/05 | 3,230 | 3,280 | 3,195 | 3,275 | +35 | +1.1% | 376,200 |
| 2025/02/04 | 3,220 | 3,250 | 3,190 | 3,240 | +35 | +1.1% | 307,700 |
| 2025/02/03 | 3,235 | 3,245 | 3,150 | 3,205 | -145 | -4.3% | 497,800 |
| 2025/01/31 | 3,335 | 3,355 | 3,280 | 3,350 | +30 | +0.9% | 481,500 |
| 2025/01/30 | 3,330 | 3,430 | 3,320 | 3,320 | -5 | -0.2% | 673,100 |
| 2025/01/29 | 3,255 | 3,325 | 3,220 | 3,325 | +70 | +2.2% | 462,700 |
| 2025/01/28 | 3,150 | 3,280 | 3,120 | 3,255 | +70 | +2.2% | 567,400 |
| 2025/01/27 | 3,200 | 3,255 | 3,155 | 3,185 | +10 | +0.3% | 581,400 |
| 2025/01/24 | 3,075 | 3,185 | 3,065 | 3,175 | +50 | +1.6% | 486,800 |
| 2025/01/23 | 3,030 | 3,130 | 2,981 | 3,125 | +80 | +2.6% | 805,100 |
| 2025/01/22 | 3,105 | 3,120 | 3,000 | 3,045 | -75 | -2.4% | 696,900 |
| 2025/01/21 | 3,125 | 3,180 | 3,105 | 3,120 | +45 | +1.5% | 426,700 |
| 2025/01/20 | 3,115 | 3,130 | 3,045 | 3,075 | -40 | -1.3% | 392,400 |
| 2025/01/17 | 3,155 | 3,165 | 3,090 | 3,115 | -60 | -1.9% | 422,500 |
| 2025/01/16 | 3,170 | 3,260 | 3,145 | 3,175 | +20 | +0.6% | 614,700 |
| 2025/01/15 | 3,105 | 3,180 | 3,090 | 3,155 | +30 | +1% | 522,500 |
| 2025/01/14 | 3,075 | 3,225 | 3,035 | 3,125 | +40 | +1.3% | 859,200 |
| 2025/01/10 | 3,100 | 3,100 | 3,045 | 3,085 | -10 | -0.3% | 317,100 |
| 2025/01/09 | 3,055 | 3,150 | 3,015 | 3,095 | -10 | -0.3% | 636,700 |
| 2025/01/08 | 3,065 | 3,110 | 3,035 | 3,105 | +50 | +1.6% | 492,200 |
| 2025/01/07 | 3,090 | 3,180 | 3,040 | 3,055 | -35 | -1.1% | 1,285,100 |
| 2025/01/06 | 3,360 | 3,370 | 3,090 | 3,090 | -315 | -9.3% | 1,777,700 |
| 2024/12/30 | 3,560 | 3,595 | 3,400 | 3,405 | -205 | -5.7% | 1,343,000 |
| 2024/12/27 | 3,420 | 3,680 | 3,420 | 3,610 | +270 | +8.1% | 2,152,900 |
| 2024/12/26 | 3,345 | 3,370 | 3,300 | 3,340 | ±0 | ±0% | 922,600 |
| 2024/12/25 | 3,400 | 3,425 | 3,315 | 3,340 | -95 | -2.8% | 993,800 |
| 2024/12/24 | 3,345 | 3,435 | 3,330 | 3,435 | +55 | +1.6% | 906,300 |
| 2024/12/23 | 3,355 | 3,450 | 3,310 | 3,380 | +165 | +5.1% | 1,349,000 |
51～
100
件表示中 / 3706件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 418,500円 | +21.7% | +999.9% | 0.00% | 17.53倍 | 5.80倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| キッセイ薬 | 390,500円 | +3.6% | +6.1% | 3.07% | 13.15倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.35倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 科研薬 | 376,600円 | -6.4% | -71.8% | 5.05% | 41.94倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 308,500円 | +7.9% | -3.3% | 2.59% | 8.58倍 | 0.88倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
